Stock MOR MORPHOSYS AG
Add to a list
To use this feature you must be a member
Log inSign up

All News MorphoSys AG

Equities

MOR

DE0006632003

Delayed Xetra
Other stock markets
 11:35:30 2024-04-30 am EDT 		5-day change 1st Jan Change
66.2 EUR +0.84% Intraday chart for MorphoSys AG -2.29% +94.71%
Apr. 30 European Equities Traded in the US as American Depositary Receipts Decline MT
Apr. 30 MORPHOSYS : UBS remains Neutral ZD

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
European Equities Traded in the US as American Depositary Receipts Decline
MT
MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
MORPHOSYS : UBS remains Neutral
ZD
Novartis target Morphosys multiplies losses - takeover schedule stands
DP
MorphoSys : 1st Quarter Interim Statement 2024
PU
MorphoSys AG Reports First Quarter 2024 Financial Results
EQ
MorphoSys AG Reports First Quarter 2024 Financial Results
BU
European Equities Traded in the US as American Depositary Receipts Nudge Higher in Monday Trading
MT
MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
Morphosys says takeover by Novartis on course after report of drug safety concern
RE
MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
MorphoSys To Present New Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation at 2024 ASCO Annual Meeting
EQ
MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MOR Stock
  4. News MorphoSys AG